Big Pharma Relief Over Trump Tariff Reprieve
Sam Fazeli, Director of Research for Global Industries, Bloomberg Intelligence
03-Oct-25 07:30
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
US President Donald Trump came into office vowing to reduce the cost of prescription drugs for the American consumer. But will that relief come at the expense of pharmaceutical balance sheets? We discuss the implications of US policy for pharma companies with Sam Fazeli of Bloomberg Intelligence.
Image Credit: Shutterstock.com
Produced by: Shazana Mokhtar
Presented by: Shazana Mokhtar, Wong Shou Ning, Keith Kam
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: markets, economy, international
Tags: trump.rx, trump tariff, pharmaceuticals, donald trump, drugs,